AEMD — Aethlon Medical Balance Sheet
0.000.00%
- $4.62m
- -$1.24m
- 17
- 45
- 13
- 13
Annual balance sheet for Aethlon Medical, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 9.86 | 17.1 | 14.5 | 5.44 | 5.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.149 | 0.128 | 0 | — | — |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 10.4 | 18.2 | 15.1 | 6.23 | 5.95 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.201 | 1.14 | 2.3 | 1.9 | 1.28 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 10.7 | 19.4 | 17.5 | 8.25 | 7.36 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.38 | 1.82 | 1.51 | 1.83 | 1.9 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 1.24 | 2.28 | 2.44 | 2.48 | 2.24 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 9.43 | 17.1 | 15.1 | 5.77 | 5.12 |
| Total Liabilities & Shareholders' Equity | 10.7 | 19.4 | 17.5 | 8.25 | 7.36 |
| Total Common Shares Outstanding |